Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-FR Version v3-EN
Language French English
Date Updated 2018-05-17 2017-12-06
Drug Identification Number 02415585 02415585
Brand name NUCYNTA EXTENDED-RELEASE NUCYNTA EXTENDED-RELEASE
Common or Proper name Nucynta Nucynta
Company Name ENDO VENTURES LTD. ENDO VENTURES LTD.
Ingredients Tapentadol Tapentadol
Strength(s) 100MG 100MG
Dosage form(s) TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 60 Tabs 60 Tabs
ATC code N02AX N02AX
ATC description OPIOIDS OPIOIDS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2017-12-30 2017-12-30
Actual start date
Estimated end date 2017-12-06
Actual end date 2017-12-30
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments